Abstract: The disclosure relates to an application device, preferably for alternately applying a 2C material, comprising a first component material and a second component material, on the one hand and the first component material on the other hand, in particular onto a motor vehicle component, comprising preferably an application head and a first line section leading to an application nozzle, wherein the first line section comprises a mixer and a first line for a first component material and a second line for a second component material, wherein the first line and the second line are connected to the mixer and the mixer mixes the first component material and the second component material with each other for forming a 2C material. The application device is characterized in particular in that it comprises a second line section for the first component material to form an application bead of alternately the 2C material from the first line section and the first component material from the second line section.

Abstract: A cable unit is provided comprising: a jacket comprising at least one cable housing and at least one support housing; the or each cable housing having a tubular structure, extending in a longitudinal direction, each support housing in the plurality of support housings having a tubular structure, extending in the longitudinal direction, wherein the at least one support housing being disposed on one side of the at least one cable housing; and at least one support element retained within each support housing of the plurality of support housings, wherein the at least one support element retained within each support housing of the plurality of support housings comprises at least one portion that has an arcuate cross section in the width direction.

Abstract: The present invention provides a method of determining chemical oxygen demand (COD) for a sample with a high concentration of chloride. The method includes obtaining the sample, determining a concentration of chloride in the sample to obtain a known concentration of chloride in the sample, dosing an amount of the sample, an acid and an oxidizing agent into a container to obtain an analyte, heating the container containing the analyte, photometrically determining a preliminary chemical oxygen demand (COD) of the analyte in an analytic device, and correcting for the high concentration of chloride using a chloride correction to obtain the chemical oxygen demand (COD).

Abstract: A liquid analysis system for a photometric determination of an analyte in a liquid sample includes an analyzer comprising a photometer, an RFID parameter reading device and an identifier reading device, and a cuvette package comprising an RFID parameter transponder and a plurality of test cuvettes of one batch. Each test cuvette comprises a reagent. Batch identification and batch-specific reagent data are stored in the RFID parameter transponder. Each test cuvette comprises a batch-specific identifier including a batch identification. The batch identification is configured to be read by the identifier reading device.

Abstract: In some implementations, a computing device can be configured to present a graphical user interface that enables the dynamic authoring of music by a user of the computing device. The computing device can present a grid of cells, where each cell represents a music segment. The cells can be configured to playback the music segment once or playback the music segment in a repeating loop. The user can select (e.g., touch) one or more cells in the grid to cause the corresponding music segment to play. While playing selected cells, the user can provide input selecting various musical effects to apply to the playing music. The user can record a dynamically selected sequence of cells and musical effects to create an original musical product.

Abstract: The present invention relates to disubstituted pyridine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted pyridine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted pyridine derivatives as inhibitors for a protein kinase.

Abstract: The present invention relates to disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted triazine derivatives as inhibitors for a protein kinase.

Abstract: The present invention relates to disubstituted pyridine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted pyridine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted pyridine derivatives as inhibitors for a protein kinase.

Abstract: The present invention relates to disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted triazine derivatives as inhibitors for a protein kinase.

Abstract: Techniques are provided for enabling a collaborative music session between multiple participants. In certain embodiments, a user may create a jam session using his/her electronic device. One or more other participants may then join the jam session using their electronic devices. The jam session participants may then jam together using their electronic devices as virtual music instruments. A musical memento of the jam session can then be stored for subsequent playback.

Abstract: A system for determining an analyte in a water sample includes at least one stationary sampling site identification transmitter at a sampling site. The at least one stationary sampling site identification transmitter is configured to wirelessly transmit a sampling site identification. A mobile sample container is configured to take a sample at the sampling site. The mobile sample container comprises a transmitter and receiver device. The transmitter and receiver device comprises a memory for the sampling site identification and for a sampling time stamp. A time stamp generator comprises a time stamp transmitter configured to wirelessly transmit the sampling time stamp. A water analysis device comprises a receiver configured to wirelessly receive the sampling site identification and the sampling time stamp from the transmitter and receiver device.

Abstract: A liquid analysis system for a photometric determination of an analyte in a liquid sample includes an analyzer comprising a photometer, an RFID parameter reading device and an identifier reading device, and a cuvette package comprising an RFID parameter transponder and a plurality of test cuvettes of one batch. Each test cuvette comprises a reagent. Batch identification and batch-specific reagent data are stored in the RFID parameter transponder. Each test cuvette comprises a batch-specific identifier including a batch identification. The batch identification is configured to be read by the identifier reading device.

Abstract: A barstool comprising a seating unit and an extension or insertion unit or both, wherein the seating unit is coupled with the extension or insertion unit or both such that the extension or insertion unit or both may be used to stow and extend the seating unit relative to a wall portion of a bar counter by inserting or pivoting the extension or insertion unit or both.